2 recruiting, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Completed 1 |
Follow Thomas Hope: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 177 Lutetium Prostate-Specific Membrane Antigen 617, Actinium-225 Prostate-Specific Membrane Antigen 617, Non-investigational, Prostatectomy - Prostate Cancer, Prostate Cancer (Diagnosis) | Phase 1 | Recruiting | Thomas Hope | 45 | 2025-07-08 | 2026-08-28 |
| Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 68Ga-FAP-2286, Positron Emission Tomography (PET) - Liver Fibrosis, Pulmonary Fibrosis | Phase 1 | Completed | Thomas Hope | 16 | 2021-12-09 | 2025-03-21 |
| Imaging of Solid Tumors Using FAP-2286 Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission Tomography (PET) imaging, Copper-64 labeled (64Cu-) FAP-2286 - Solid Tumors, Adult, Metastatic Cancer | Phase 1 | Recruiting | Thomas Hope | 191 | 2020-12-14 | 2026-06-04 |
Disease (1) · Liver Cirrhosis (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Pulmonary Fibrosis (1)
Magnetic Resonance Spectroscopy (2) · (225)Ac-PSMA-617 (1) · Blood Specimen Collection (1) · Pluvicto (1) · Prostatectomy (1)
United States (3)